Trials / Conditions / Bile Acid Malabsorption

Bile Acid Malabsorption

16 registered clinical trials studyying Bile Acid Malabsorption — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Magnesium in Gastrointestinal Disease NCT07338565	University of Aarhus	—
Recruiting	Treatment of Bile Acid Diarrhoea With Atorvastatin NCT07042165	Asger Lund, MD	Phase 4
Recruiting	Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide NCT07429864	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	—
Recruiting	Probiotic in Patients With Bile Acid Malabsorption/Diarrhea NCT06609148	Mayo Clinic	N/A
Recruiting	Bile Acids and Microbiome in Early Colorectal Carcinogenesis NCT06502704	Vilnius University	—
Completed	Serum Metabolics-based Method for Diagnosing Bile Acid Diarrhoea NCT06548009	University Hospital, Gentofte, Copenhagen	—
Unknown	Impact of Foods on Bile Acids, Metabolites, and Inflammation NCT05245357	Montana State University	N/A
Completed	Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM) NCT05130047	Michael Camilleri, MD	Phase 2
Completed	Treatment of Bile Acid Malabsorption With Liraglutide NCT03955575	Filip Krag Knop	Phase 4
Completed	Effect of the Sequestrant Colesevelam in Bile Acid Diarrhoea NCT03876717	Lars Kristian Munck	Phase 4
Completed	Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption NCT03270085	Mayo Clinic	Phase 2
Completed	Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy NCT03168555	Zealand University Hospital	Phase 4
Completed	Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea NCT03059537	Lars Kristian Munck	Phase 4
Completed	A Study of Colesevelam in Fecal Incontinence NCT02628626	Mayo Clinic	Phase 3
Completed	Double-blind, Randomised Study of A3384 in BAM/BAD NCT02078856	Albireo	Phase 2
Terminated	Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease NCT01203254	Florian Beigel	Phase 4